Growth hormone and cardiovascular risk markers

Area of Science:

• Cardiovascular Endocrinology
• Vascular Biology
• Endocrinology

Background:

• Growing evidence links hypopituitarism and growth hormone (GH) deficiency to elevated cardiovascular mortality.
• GH deficiency in adults, regardless of onset age, is associated with increased atherosclerotic plaques and endothelial dysfunction.
• Subclinical atherosclerosis is more prevalent in hypopituitarism patients.

Purpose of the Study:

• To investigate the association between hypopituitarism and GH deficiency with cardiovascular disease.
• To explore the prevalence of atherosclerosis and specific vascular abnormalities in GH-deficient adults.

Main Methods:

• Review of existing literature on hypopituitarism, GH deficiency, and cardiovascular outcomes.
• Analysis of studies utilizing high-resolution ultrasonography to assess atherosclerosis.
• Examination of anatomical abnormalities such as increased intimal-medial wall thickness.

Main Results:

• Patients with hypopituitarism and GH deficiency exhibit a higher prevalence of premature atherosclerosis.
• Vascular abnormalities, including increased intimal-medial wall thickness, are observed in GH-deficient adults.
• High-resolution ultrasonography reveals subclinical atherosclerosis in these patients.

Conclusions:

• Hypopituitarism and GH deficiency are significant risk factors for premature atherosclerosis and cardiovascular complications.
• Further research is needed to clarify the roles of hormonal factors and prior irradiation in vascular disease development.
• Early detection and management of vascular risks in GH-deficient individuals are crucial.